The Chefs' Warehouse (CHEF) Q2 2026 earnings review
Record Acceleration and a Massive Guidance Raise
The Chefs’ Warehouse delivered a flawless quarter, posting its fifth consecutive period of accelerating revenue growth (+12.9% YoY). The volume engine is firing on all cylinders, driving immense operating leverage that expanded Adjusted EBITDA by 34.7% YoY. The Middle East business is successfully reversing its conflict-driven decline, recovering to 94% of prior-year levels. With margins expanding across both key segments, management issued a massive upward revision to full-year guidance, raising the Adjusted EBITDA midpoint by nearly $30 million.
🐂 Bull Case
A 12.9% revenue gain translated to a 34.7% surge in Adjusted EBITDA. Years of investment in infrastructure and sales force training are generating tremendous flow-through.
Organic specialty case count grew 6.0% and center-of-the-plate pounds jumped 8.8%. The company is taking market share through unique item placements (+7.2%) without relying on price inflation.
🐻 Bear Case
Despite the massive guidance raise, the implied revenue growth for H2 2026 is roughly 7.4%, suggesting a sharp deceleration from H1's 12.2% pace. Management is likely maintaining historical conservatism.
The effective tax rate spiked to 31.4% from 28.0% due to permanent differences related to compensation, dragging down bottom-line flow-through despite the operating margin success.
⚖️ Verdict: 🟢
Bullish. It is rare to see a company accelerate top-line growth for five consecutive quarters while simultaneously expanding margins by over 100 basis points. The raised guidance confirms this is not a one-off anomaly.
Key Themes
Accelerating Organic Volume
The company's core volume metrics are accelerating cleanly, shedding the 'noise' of recent quarters caused by deliberate program attrition in Texas. Organic specialty case count increased 6.0% and center-of-the-plate pounds sold grew an impressive 8.8%. Unique customer placements grew 7.2%, proving the cross-selling strategy is winning share of wallet.
Operating Leverage Hits an Inflection Point
Operating margin expanded from 3.9% to 5.1%, and gross profit margin climbed 49 basis points to 25.1%. Management previously stated they were in the 'early innings' of leveraging facility consolidations and routing efficiencies; this quarter provides concrete proof that the fixed-cost infrastructure can now generate outsized profit growth on incremental volume.
Technology-Driven Operational Efficiency
The continuous improvement in operational efficiency is deeply tied to the company's innovation in digital ordering platforms. With over 60% of specialty orders historically originating online, the sales force is spending less time on administrative tasks and more time driving the 7.2% increase in unique placements. This digital scale is the unsung hero of the SG&A leverage story.
Middle East Conflict Drag is Reversing
Macro risk in the Middle East was the primary reason management held guidance flat in Q1 (when regional operations dipped to 75% of prior-year levels). In Q2, the company reported the region had improved to ~94% of prior year during May and June. This normalization removes the largest near-term macro overhang from the stock.
Tax Rate Spike Contradicts Margin Narrative
While the operational story is flawless (operating income +45%), the ultimate translation to Net Income was slightly dulled by a rising tax burden. The effective tax rate jumped to 31.4% (vs 28.0% a year ago). Management specifically attributed this to increased permanent tax differences related to compensation expense, a structural drag that investors must model going forward.
Blowout Cash Flow, But Buybacks Paused
A notable contradiction emerged in capital allocation. Year-to-date operating cash flow surged to $96.7 million. Management constantly preaches an 'opportunistic' share buyback strategy. Yet, the H1 cash flow statement shows $10.0 million spent on repurchases—the exact amount reported in Q1. This means the company repurchased $0 in stock during a blowout Q2, raising questions about potential M&A hoarding or valuation concerns.
Absolute SG&A Dollar Growth Remains High
While SG&A as a percentage of sales improved (20.0% vs 20.7%), absolute SG&A expenses still grew 9.6% YoY to $234.2 million. The company continues to face high costs associated with compensation, facilities, and fleet investments. If top-line growth were to decelerate, this elevated cost base would quickly compress margins.
Other KPIs
Accelerating. Up 49 basis points YoY. Both reporting segments contributed to the beat, with the Specialty category up 47 bps and the Center-of-the-Plate category up 75 bps. The ability to expand margins while simultaneously driving 8.8% volume growth in proteins is exceptional.
Accelerating. Up 50.8% from $64.1 million in the same period last year. The surge was driven entirely by higher net income and better inventory management (inventory was a $5.4M source of cash in H1 2026 vs a $51.4M use of cash in H1 2025).
Guidance
Raised significantly from the prior $4.35-$4.45B range. However, mathematical deduction reveals a decelerating H2. H1 actual revenue was $2.22B. To hit the $4.55B midpoint, H2 revenue must be ~$2.32B. Compared to H2 2025 ($2.16B), this implies ~7.4% YoY growth in the back half of the year, a sharp deceleration from Q2's 12.9% pace. This indicates management is leaving a thick cushion of conservatism.
Massive acceleration vs initial expectations. Raised by nearly $30M at the midpoint (from $281M). The new midpoint implies full-year Adjusted EBITDA margins of ~6.8%, compared to roughly 6.0% achieved in FY25.
Key Questions
H2 Deceleration vs Conservatism
Your raised revenue guidance still implies a step-down to mid-single-digit growth in the second half. Are you seeing any macro indicators that suggest a slowdown, or is this standard conservatism heading into the fall?
Capital Allocation Shift
Operating cash flow was outstanding this quarter, yet stock repurchases halted entirely in Q2 after deploying $10 million in Q1. Given the raised EBITDA outlook, why not accelerate buybacks at these levels? Is there a larger M&A target in the pipeline?
Permanent Tax Differences
The effective tax rate climbed to 31.4% driven by permanent differences in compensation expense. Should we expect this low-30s tax rate to be the new normal moving forward, and how does it impact your long-term free cash flow conversion targets?
Middle East Trajectory
With the Middle East recovering to 94% of prior year in May and June, do you anticipate this segment crossing back into positive YoY growth by Q4, or are structural changes in the region capping the ceiling?